Search

Warren A Young

Examiner (ID: 12325)

Most Active Art Unit
1711
Art Unit(s)
1711
Total Applications
3
Issued Applications
0
Pending Applications
0
Abandoned Applications
3

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15457335 [patent_doc_number] => 20200041492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => BIOMARKERS FOR CELLULAR SENESCENCE [patent_app_type] => utility [patent_app_number] => 16/492410 [patent_app_country] => US [patent_app_date] => 2018-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492410 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/492410
BIOMARKERS FOR CELLULAR SENESCENCE Mar 8, 2018 Pending
Array ( [id] => 14808831 [patent_doc_number] => 20190271025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => METHOD TO DETECT PRE-SYMPTOM EARLY CANCER WITH ENHANCED ACCURACY [patent_app_type] => utility [patent_app_number] => 15/912153 [patent_app_country] => US [patent_app_date] => 2018-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912153 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/912153
METHOD TO DETECT PRE-SYMPTOM EARLY CANCER WITH ENHANCED ACCURACY Mar 4, 2018 Abandoned
Array ( [id] => 13444993 [patent_doc_number] => 20180274039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => METHYLATION MARKERS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA AND LUNG CANCER [patent_app_type] => utility [patent_app_number] => 15/910857 [patent_app_country] => US [patent_app_date] => 2018-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910857 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/910857
Methylation markers for diagnosing hepatocellular carcinoma and lung cancer Mar 1, 2018 Issued
Array ( [id] => 18825463 [patent_doc_number] => 11840734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-12 [patent_title] => Method for analyzing aurka expression [patent_app_type] => utility [patent_app_number] => 16/494949 [patent_app_country] => US [patent_app_date] => 2018-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 5 [patent_no_of_words] => 29767 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494949 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494949
Method for analyzing aurka expression Feb 28, 2018 Issued
Array ( [id] => 17075154 [patent_doc_number] => 11111540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-07 [patent_title] => Assessment of risk of aneuploidy [patent_app_type] => utility [patent_app_number] => 15/905665 [patent_app_country] => US [patent_app_date] => 2018-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13332 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905665 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/905665
Assessment of risk of aneuploidy Feb 25, 2018 Issued
Array ( [id] => 16832383 [patent_doc_number] => 11008624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-05-18 [patent_title] => Methods for predicting prostate cancer relapse [patent_app_type] => utility [patent_app_number] => 15/890789 [patent_app_country] => US [patent_app_date] => 2018-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20689 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890789 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/890789
Methods for predicting prostate cancer relapse Feb 6, 2018 Issued
Array ( [id] => 16073195 [patent_doc_number] => 20200190584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => HSMI DISEASE RESISTANCE IN SALMONIDS [patent_app_type] => utility [patent_app_number] => 16/481807 [patent_app_country] => US [patent_app_date] => 2018-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/481807
HSMI disease resistance in salmonids Jan 29, 2018 Issued
Array ( [id] => 12838732 [patent_doc_number] => 20180171417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN KRAS [patent_app_type] => utility [patent_app_number] => 15/878851 [patent_app_country] => US [patent_app_date] => 2018-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878851 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/878851
DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN KRAS Jan 23, 2018 Abandoned
Array ( [id] => 17497832 [patent_doc_number] => 11286525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Gene expression signatures useful to predict or diagnose sepsis and methods of using the same [patent_app_type] => utility [patent_app_number] => 16/478202 [patent_app_country] => US [patent_app_date] => 2018-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 19927 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478202 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/478202
Gene expression signatures useful to predict or diagnose sepsis and methods of using the same Jan 15, 2018 Issued
Array ( [id] => 13462537 [patent_doc_number] => 20180282811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS [patent_app_type] => utility [patent_app_number] => 15/870945 [patent_app_country] => US [patent_app_date] => 2018-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870945 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/870945
METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS Jan 12, 2018 Abandoned
Array ( [id] => 12770887 [patent_doc_number] => 20180148797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => POLYNUCLEOTIDE PROBE, METHOD FOR DETECTING A TARGET NUCLEIC ACID BY USING THE SAME AND KIT COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 15/870336 [patent_app_country] => US [patent_app_date] => 2018-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7037 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870336 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/870336
Polynucleotide probe, method for detecting a target nucleic acid by using the same and kit comprising the same Jan 11, 2018 Issued
Array ( [id] => 13300935 [patent_doc_number] => 20180202004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS [patent_app_type] => utility [patent_app_number] => 15/858703 [patent_app_country] => US [patent_app_date] => 2017-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75352 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858703 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/858703
Methods for predicting drug responsiveness in cancer patients Dec 28, 2017 Issued
Array ( [id] => 18518728 [patent_doc_number] => 11708611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Method for diagnosing prostatic disease via bacterial metagenomic analysis [patent_app_type] => utility [patent_app_number] => 16/474543 [patent_app_country] => US [patent_app_date] => 2017-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9320 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 701 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/474543
Method for diagnosing prostatic disease via bacterial metagenomic analysis Dec 26, 2017 Issued
Array ( [id] => 16169751 [patent_doc_number] => 10711302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Predicting resistance to disease [patent_app_type] => utility [patent_app_number] => 15/848434 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6720 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848434 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/848434
Predicting resistance to disease Dec 19, 2017 Issued
Array ( [id] => 12707962 [patent_doc_number] => 20180127820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => PREDICTING RESISTANCE TO DISEASE [patent_app_type] => utility [patent_app_number] => 15/848386 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6749 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848386 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/848386
Predicting resistance to disease Dec 19, 2017 Issued
Array ( [id] => 15148453 [patent_doc_number] => 20190352704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => BENIGN THYROID NODULE-SPECIFIC GENE [patent_app_type] => utility [patent_app_number] => 16/467573 [patent_app_country] => US [patent_app_date] => 2017-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4801 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467573 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/467573
BENIGN THYROID NODULE-SPECIFIC GENE Dec 6, 2017 Abandoned
Array ( [id] => 12746233 [patent_doc_number] => 20180140578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND SELECTIVE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/821111 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32325 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821111 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/821111
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND SELECTIVE TREATMENT OF CANCER Nov 21, 2017 Abandoned
Array ( [id] => 12751399 [patent_doc_number] => 20180142300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => UNIVERSAL HAPLOTYPE-BASED NONINVASIVE PRENATAL TESTING FOR SINGLE GENE DISEASES [patent_app_type] => utility [patent_app_number] => 15/818138 [patent_app_country] => US [patent_app_date] => 2017-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29030 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 388 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15818138 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/818138
UNIVERSAL HAPLOTYPE-BASED NONINVASIVE PRENATAL TESTING FOR SINGLE GENE DISEASES Nov 19, 2017 Abandoned
Array ( [id] => 13358003 [patent_doc_number] => 20180230541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => METHOD FOR PREDICTING THE ONSET OF EXTRAPYRAMIDAL SYMPTOMS (EPS) INDUCED BY AN ANTIPSYCHOTIC-BASED TREATMENT [patent_app_type] => utility [patent_app_number] => 15/815967 [patent_app_country] => US [patent_app_date] => 2017-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8953 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815967 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/815967
Method for predicting the onset of extrapyramidal symptoms (EPS) induced by an antipsychotic-based treatment Nov 16, 2017 Issued
Array ( [id] => 14930657 [patent_doc_number] => 20190300966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => Methods for Diagnosing Cancer [patent_app_type] => utility [patent_app_number] => 16/335605 [patent_app_country] => US [patent_app_date] => 2017-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335605 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335605
Methods for diagnosing cancer Nov 7, 2017 Issued
Menu